Related Experiment Videos
Optimization of gene transfer into intestinal epithelial cells using a retroviral vector
R A Noel1, P Shukla, S J Henning
1Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.
Journal of Pediatric Gastroenterology and Nutrition
|July 1, 1994
Summary
Somatic gene therapy using retroviruses can target intestinal cells. Researchers used rat intestinal crypt cells (IEC-6) to model gene transfer, finding it feasible for treating metabolic diseases.
Area of Science:
- Biotechnology
- Molecular Biology
- Gastroenterology
Background:
- Somatic gene therapy offers potential for treating metabolic diseases linked to secretory protein deficiencies.
- The intestine is a promising target for gene therapy due to its accessibility and rapid cell turnover.
Purpose of the Study:
- To evaluate the feasibility and dynamics of retroviral gene transfer in intestinal cells using an in vitro model.
- To assess gene transfer efficiency in IEC-6 cells, a rat intestinal crypt cell line.
Main Methods:
- Utilized a replication-deficient retrovirus to deliver a bacterial beta-galactosidase (beta-gal) reporter gene.
- Transduced NIH-3T3 fibroblasts and IEC-6 cells, measuring success via X-gal histochemistry.
- Optimized retroviral concentration, harvest time, plating density, and infection multiplicity.
Main Results:
- IEC-6 cells showed lower viral titers than NIH-3T3 cells but were comparable.
- Gene transfer efficiency increased linearly with retroviral concentration up to a 1:5 dilution.
- Undiluted viral medium inhibited gene transfer, particularly in IEC-6 cells, an effect mitigated by shorter harvest times.
Conclusions:
- Retroviral gene transfer is feasible in IEC-6 cells, serving as a viable in vitro model for intestinal gene therapy.
- Optimal conditions, including viral concentration and cell plating density, are crucial for efficient gene transfer.
- Further optimization can achieve gene transfer efficacy in IEC-6 cells comparable to other cell lines.